Selected article for: "current diagnostic and diagnostic reagent"

Author: Cheong, Wei Shien; Leow, Chiuan Yee; Abdul Majeed, Abu Bakar; Leow, Chiuan Herng
Title: Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody
  • Cord-id: zt3e64ap
  • Document date: 2020_3_15
  • ID: zt3e64ap
    Snippet: Conventional monoclonal antibodies (mAbs) have been widely used in research and diagnostic applications due to their high affinity and specificity. However, multiple limitations, such as large size, complex structure and sensitivity to extreme ambient temperature potentially weaken the performance of mAbs in certain applications. To address this problem, the exploration of new antigen binders is extensively required in relation to improve the quality of current diagnostic platforms. In recent ye
    Document: Conventional monoclonal antibodies (mAbs) have been widely used in research and diagnostic applications due to their high affinity and specificity. However, multiple limitations, such as large size, complex structure and sensitivity to extreme ambient temperature potentially weaken the performance of mAbs in certain applications. To address this problem, the exploration of new antigen binders is extensively required in relation to improve the quality of current diagnostic platforms. In recent years, a new immunoglobulin-based protein, namely variable domain of new antigen receptor (VNAR) was discovered in sharks. Unlike conventional mAbs, several advantages of VNARs, include small size, better thermostability and peculiar paratope structure have attracted interest of researchers to further explore on it. This article aims to first present an overview of the shark VNARs and outline the characteristics as an outstanding new reagent for diagnostic and therapeutic applications.

    Search related documents:
    Co phrase search for related documents
    • active site and low efficiency: 1, 2, 3
    • active site and low nanomolar range: 1, 2
    • acute respiratory syndrome and additional diversity: 1
    • acute respiratory syndrome and long variable: 1, 2
    • acute respiratory syndrome and loop length: 1
    • acute respiratory syndrome and low efficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory syndrome and low resource: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and mabs efficacy: 1
    • acute respiratory syndrome and mabs monoclonal antibody: 1, 2, 3, 4, 5, 6, 7